S80874 |
Pergolide Mesylate |
源葉(MedMol) | 99% |
1mg | 5mg | 10mg | |
---|---|---|---|
1 mM | 2.435 ml | 12.177 ml | 24.355 ml |
5 mM | 0.487 ml | 2.435 ml | 4.871 ml |
10 mM | 0.244 ml | 1.218 ml | 2.435 ml |
50 mM | 0.049 ml | 0.244 ml | 0.487 ml |
- 提示:詳情請(qǐng)下載說明書。
- 產(chǎn)品描述: Pergolide mesylate (Pergolide methanesulfonate), an Ergoline derivative, is a potent and orally active dopamine D1 and D2 receptors agonist. Pergolide mesylate can be used for Parkinson's disease and hyperprolactinaemia research
- 靶點(diǎn): D2 Receptor;D1 Receptor;DopamineReceptor;5-HTReceptor;AdrenergicReceptor
- 體內(nèi)研究:
Pergolide (0.3 mg/kg; intraperitoneal injection; daily; 11 days) treatment reduces the number of working/reference memory errors a 6-OHDA-induced rat model of Parkinson's disease. Pergolide facilitates spatial memory and improves brain oxidative balance
- 參考文獻(xiàn):
1. S Franks, et al. Effectiveness of pergolide mesylate in long term treatment of hyperprolactinaemia. Br Med J (Clin Res Ed). 1983 Apr 9;286(6372):1177-9. 2. Daniela Uberti, et al. Pergolide protects SH-SY5Y cells against neurodegeneration induced by H(2)O(2). Eur J Pharmacol. 2002 Jan 2;434(1-2):17-20. 3. Alin Ciobica, et al. The effects of pergolide on memory and oxidative stress in a rat model of Parkinson's disease. J Physiol Biochem. 2012 Mar;68(1):59-69.
- 溶解性: DMSO : ≥ 25 mg/mL (60.89 mM)
- 保存條件: -20℃
- 配置溶液濃度參考:
1mg 5mg 10mg 1 mM 2.435 ml 12.177 ml 24.355 ml 5 mM 0.487 ml 2.435 ml 4.871 ml 10 mM 0.244 ml 1.218 ml 2.435 ml 50 mM 0.049 ml 0.244 ml 0.487 ml
- 注意:部分產(chǎn)品我司僅能提供部分信息,我司不保證所提供信息的權(quán)威性,僅供客戶參考交流研究之用。
輸入產(chǎn)品批號(hào):
本計(jì)算器可幫助您計(jì)算出特定溶液中溶質(zhì)的質(zhì)量、溶液濃度和體積之間的關(guān)系,公式為:
質(zhì)量 (mg) = 濃度 (mM) x 體積 (mL) x 分子摩爾量 (g/mol)